sometimes, They might propose many remedies at the same time. However, the prevailing research hasn't decided whether it is more practical than an individual treatment. Under the pilot, the FDA notified registries that participated from the pilot – general public curiosity Registry, Registry Services (formerly Neustar) and Verisign – once the